27 Oct 2020 07:00
RNS Number : 2136D
Benchmark Holdings PLC
27 October 2020
27 October 2020
Benchmark Holdings plc
("Benchmark" or the "Company")
Notice of Full Year Results
Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will announce its full year results, for the period ended 30 September 2020, on Friday 27 November 2020.
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts on that day at 8:30am UK time. To register your interest, please contact benchmark@mhpc.com.
Enquiries
For further information, please contact: |
| Benchmark Holdings plc | Tel: 020 3696 0630 | Trond Williksen, CEO |
| Septima Maguire, CFO |
| Ivonne Cantu, Investor Relations |
|
|
|
|
| Numis (Broker and NOMAD) | Tel: 020 7260 1000 | James Black, Freddie Barnfield, Duncan Monteith |
|
|
| MHP Communications | Tel: 020 3128 8990 | Katie Hunt, Reg Hoare, Alistair de Kare-Silver, Charlie Protheroe | benchmark@mhpc.com |
|
|
|
|
|
|
About Benchmark
Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.
We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NORFQLFLBBLEFBB